Wilmington Healthcare has worked closely with NHS and industry cancer stakeholders for some years. With our unique range of services and oncology expertise we can enable partnership and engagement with the NHS and help you tailor your value proposition to optimise your results.
The landscape of cancer care is changing rapidly. Faster cancer diagnosis is a key ambition of the NHS Long-term Plan, which says that the proportion of cancers diagnosed at stages one and two should rise from around half now, to three quarters of cancer patients by 2028.
Raising greater awareness of the symptoms of cancer, lowering the threshold for referral by GPs, accelerating access to diagnosis and treatment and maximising the number of cancers identified through screening will be key to achieving this goal.
We have put together a collection of key resources that explore the challenges for the NHS and industry in improving cancer diagnosis and care.
[Video] Join the conversation: Oncology
The alignment of services is essential for the success of so many new cancer products and companion diagnostics and the associated improvement of outcomes for patients benefiting from treatment at an earlier stage. We discuss how important it is to understand the new integrated systems.
[Article] The Times Combating Cancer supplement
Through leading analysis and commentary, The Times Combating Cancer supplement showcases current trends in oncology, as well as offering insights into the future of treatment. It draws on thoughts of leading thinkers in the field, including renowned academics, Wilmington Healthcare and other industry leaders.
Primary Care Networks
As the NHS aims to move more care out of hospitals, Primary Care Networks (PCNs) are expected to play an important role in transforming cancer services. Wilmington Healthcare has comprehensive customer data on these. We also have a variety of resources to help you understand PCNs and support you in aligning your value proposition to their agenda. Learn more.
Wilmington Healthcare holds contact data on all cancer alliances and all cancer alliance board members. We can also identify cancer alliance stakeholders by subspecialty, from a wide variety of cancer types.
We also provide data across cancer alliances and CCGs on waiting times and diagnostic stages. This data can be visualised via our Quantis product to produce heat maps of where the greatest challenges are, and where such diagnostic waits could be hampering survival from your therapies – plus many other useful presentation tools to help highlight the story you want to take to oncology decision-makers.
Our Investigator and Specialism in Focus products can help you navigate the cancer landscape, including cancer policy documentation made at local level.
Oncology in the NHS – new course
Our expert course from the Digital Learning Academy introduces the oncology landscape and is perfect for industry professionals who are new to the therapy area, or for those who need a refresher on the principal developments in cancer over the past couple of years
Contact us to discuss how we can help you identify your NHS oncology customers and engage them more effectively by tailoring your value proposition to their localised needs. Complete the form below or speak to your Wilmington Healthcare account director who will be happy to help you.
The HSJ National Cancer Forum brings together core stakeholders from across the cancer community to hear from leaders on national policy, discuss practical solutions to current challenges and to take a forward look at some of the most exciting innovations and ground-breaking work in the sector. Register your interest here.
Call 01268 495600, email firstname.lastname@example.org or fill in the form.